BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10915591)

  • 1. Summary of product characteristic: the next step to harmonization registration requirements for veterinary medicinal products in Poland.
    Sztabińska-Koncka H
    Regul Toxicol Pharmacol; 2000 Jun; 31(3):311-2. PubMed ID: 10915591
    [No Abstract]   [Full Text] [Related]  

  • 2. Marketing authorization of veterinary medicinal products in Poland.
    Sztabińska-Koncka H; Lewicki J
    Regul Toxicol Pharmacol; 1997 Aug; 26(1 Pt 1):129-33. PubMed ID: 9339489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International Cooperation on Harmonisation of Technical Requirements for Approval of Veterinary Medicinal Products (VICH); final guidance for industry on "studies to evaluate the safety of residues of veterinary drugs in human food: genotoxicity testing" (VICH GL23); availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(3):602-3. PubMed ID: 12358039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International Cooperation on Harmonisation of Technical requirements for Approval of Veterinary Medicinal Products (VICH); final guidance on " Safety studies for veterinary drug residues in human food: reproduction toxicity testing" (VICH GL22); availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2002 Jan; 67(3):603-5. PubMed ID: 12365425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Off-label use and the 'explanation'].
    Kamphuis A; de Groot SJ
    Tijdschr Diergeneeskd; 2003 May; 128(10):340-1. PubMed ID: 12793041
    [No Abstract]   [Full Text] [Related]  

  • 6. International harmonization issues.
    Thompson SR
    Vet Clin North Am Food Anim Pract; 1999 Mar; 15(1):181-95, x. PubMed ID: 10088218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The change of the new veterinary drug legislation for delivery of veterinary drugs].
    Schutte F
    Tijdschr Diergeneeskd; 2006 Jan; 131(2):54-5. PubMed ID: 16454094
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk analysis rules for the establishing of maximum residue limits of veterinary medicinal products].
    Zmudzki J
    Rocz Panstw Zakl Hig; 2003; 54 Suppl():12-3. PubMed ID: 12884488
    [No Abstract]   [Full Text] [Related]  

  • 9. Licensing and Approval of Antimicrobial Agents for Use in Animals.
    Pomba C; Catry B; Edo JT; Jukes H
    Microbiol Spectr; 2018 Aug; 6(4):. PubMed ID: 30073947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulatory harmonization--a vaccine industry perspective.
    Goodrich TD
    Dev Biol Stand; 1997; 90():355-61. PubMed ID: 9270864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Licensed drugs for small ruminants].
    Emmerich IU
    Tierarztl Prax Ausg G Grosstiere Nutztiere; 2011; 39(4):241-50. PubMed ID: 22138833
    [No Abstract]   [Full Text] [Related]  

  • 12. Congress considers minor use/minor species bill.
    J Am Vet Med Assoc; 2001 Jul; 219(1):7-8. PubMed ID: 11439774
    [No Abstract]   [Full Text] [Related]  

  • 13. The NRSP-7 project as it relates to the aquaculture industry.
    Miller LR; Ringer RK
    Vet Hum Toxicol; 1998; 40 Suppl 2():2-3. PubMed ID: 9823573
    [No Abstract]   [Full Text] [Related]  

  • 14. Requirements for Foreign and Domestic Establishment Registration and Listing for Human Drugs, Including Drugs That Are Regulated Under a Biologics License Application, and Animal Drugs. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2016 Aug; 81(169):60169-224. PubMed ID: 27580511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of field trials and data collection as part of the Investigational New Animal Drug Application (INAD).
    Oriani JA; Bell TA
    Vet Hum Toxicol; 1998; 40 Suppl 2():43-7. PubMed ID: 9823585
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mutual recognition: experiences and problems in various countries].
    Van den Eede C
    Tijdschr Diergeneeskd; 1998 Jan; 123(2):54-6. PubMed ID: 9537076
    [No Abstract]   [Full Text] [Related]  

  • 17. Canadian regulatory requirements for recombinant fish vaccines.
    Sethi MS; Gifford GA; Samagh BS
    Dev Biol Stand; 1997; 90():347-53. PubMed ID: 9270863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. International Conference on Harmonisation; guidance on M4 common technical document; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2001 Oct; 66(200):52634-7. PubMed ID: 12358037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Committee for Recommendation of Veterinary Products].
    ;
    Tijdschr Diergeneeskd; 2006 Mar; 131(5):169-70. PubMed ID: 16532790
    [No Abstract]   [Full Text] [Related]  

  • 20. An international collaborative study on a method for determination of formaldehyde in veterinary vaccines.
    Ross PF; Draayer H; Itoh O
    Biologicals; 2002 Mar; 30(1):37-41. PubMed ID: 11846428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.